Theriva Biologics Inc.

AMEX: TOVX · Real-Time Price · USD
0.49
-0.02 (-3.54%)
At close: Jul 24, 2025, 3:59 PM

Theriva Biologics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.09 -0.38 -0.35 -58.51
PEG Ratio
0.00 0.03 -0.00 0.75
PS Ratio
n/a n/a n/a n/a
PB Ratio
0.12 0.17 0.13 12.68
P/FCF Ratio
-0.14 -0.36 -0.36 -64.27
P/OCF Ratio
-0.14 -0.36 -0.37 -64.34
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
0.08 0.05 0.03 0.02
Quick Ratio
2.15 4.07 6.48 19.37
Current Ratio
2.15 4.07 6.45 19.37
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-1.35 -0.46 -0.36 -0.22
Return on Assets
-0.73 -0.33 -0.27 -0.2
Return on Invested Capital
-0.91 -0.4 -0.31 -0.21
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a